Alzheimer's Disease Clinical Trial
Official title:
Gray Matters: Multi-domain Lifestyle Behavioral Alzheimer's Disease Prevention Randomized Controlled Trial
Verified date | December 2015 |
Source | Utah State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
This is a randomized controlled trial to develop and test the efficacy of a multi-domain lifestyle behavioral intervention designed to promote healthier lifestyle behaviors linked to lower Alzheimer's disease risk among persons aged 40 to 64 years.
Status | Completed |
Enrollment | 146 |
Est. completion date | December 2014 |
Est. primary completion date | December 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 40 Years to 64 Years |
Eligibility |
Inclusion Criteria: - Age - Residing or working in Cache County Utah - Possessing smart phone or tablet Exclusion Criteria: - Dementia - Pregnancy - Untreated chronic major depression or other psychiatric condition - Body mass index > 41 - Heart or stroke in prior 6 weeks - Active cancer treatment - Unwillingness to seek medical help when serious condition identified at intake |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Utah State University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Picture Vocabulary | Picture Vocabulary cognitive test score | up to 7 months | No |
Primary | Flanker Inhibitory Control and Attention Test | Flanker Inhibitory Control and Attention Test cognitive test score | up to 7 months | No |
Primary | List Sorting Working Memory Test | List Sorting Working Memory Test cognitive test score | up to 7 months | No |
Primary | Oral Symbol Digit Test | Oral Symbol Digit Test cognitive test score | up to 7 months | No |
Primary | Montreal Cognitive Assessment | Montreal Cognitive Assessment test score | up to 7 months | No |
Primary | Rey Auditory Verbal Learning Test | Rey Auditory Verbal Learning Test score | up to 7 months | No |
Primary | Controlled Oral Word Association Test | Controlled Oral Word Association Test score | up to 7 months | No |
Primary | Blood pressure | Systolic and diastolic blood pressure | up to 7 months | No |
Primary | Body mass index | Height and weight measurement for computing body mass index | up to 7 months | No |
Primary | Insulin | insulin from venipuncture blood sample | up to 7 months | Yes |
Primary | Systemic inflammation | C-reactive protein from venipuncture blood sample | up to 7 months | Yes |
Primary | Skin carotenoid status | Biophotonic device that shines a light-emitting diode (LED) light at a site on the palm, to measure the skin carotenoid level in units of Raman counts | up to 7 months | No |
Primary | Triglycerides | triglycerides from venipuncture blood sample | up to 7 months | Yes |
Primary | HDL Cholesterol | High-density lipoprotein from venipuncture blood sample | up to 7 months | Yes |
Primary | LDL Cholesterol | Low-density lipoprotein from venipuncture blood sample | up to 7 months | Yes |
Primary | Total cholesterol | Total cholesterol from venipuncture blood sample | up to 7 months | Yes |
Secondary | Depression | Center for Epidemiologic Studies - Depression scale score | up to 7 months | No |
Secondary | Motivation | Situational Motivation Scale score | up to 7 months | No |
Secondary | Sleep Quality | Pittsburgh Sleep Quality Index scale score | up to 7 months | No |
Secondary | Stress | Perceived Stress Scale score | up to 7 months | No |
Secondary | Emotional Support | Emotional Support subscale from the NIH Toolbox measures for social engagement | up to 7 months | No |
Secondary | Friendship | Friendship subscale from the NIH Toolbox measures for social engagement | up to 7 months | No |
Secondary | Hostility | Hostility subscale from the NIH Toolbox measures for social engagement | up to 7 months | No |
Secondary | Loneliness | Loneliness subscale from the NIH Toolbox measures for social engagement | up to 7 months | No |
Secondary | Physical Activity - Moderate | self-report question concerning # minutes per day doing moderate intensity physical activity (per Center for Disease Control definition) | up to 7 months | No |
Secondary | Physical Activity - Vigorous | self-report question concerning # minutes per day doing vigorous intensity physical activity (per Center for Disease Control definition) | up to 7 months | No |
Secondary | Nutrition | Diet History Questionnaire | up to 7 months | No |
Secondary | Readiness for Change | Revised University of Rhode Island Change Assessment (R-URICA) readiness for change scale | up to 7 months | No |
Secondary | Metacognition | Total score from a set of seven items (1=much worse to 5=much better), comparing current memory to how it was three years ago, adapted from a questionnaire of functional ability | up to 7 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Withdrawn |
NCT03316898 -
A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease
|
Phase 1 | |
Withdrawn |
NCT02860065 -
CPC-201 Alzheimer's Disease Type Dementia: PET Study
|
Phase 2 | |
Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
Recruiting |
NCT05607615 -
A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease
|
Phase 2 | |
Terminated |
NCT03307993 -
Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease
|
Phase 1 | |
Recruiting |
NCT02912936 -
A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease
|
N/A | |
Active, not recruiting |
NCT02899091 -
Evaluation of the Safety and Potential Therapeutic Effects of CB-AC-02 in Patients With Alzheimer's Disease
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT02868905 -
Identification of Epigenetic Markers Common to Obesity and Alzheimer's Disease in Women
|
N/A | |
Completed |
NCT02907567 -
Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease
|
Phase 1/Phase 2 | |
Completed |
NCT02516046 -
18F-AV-1451 Autopsy Study
|
Phase 3 | |
Terminated |
NCT02521558 -
Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's Disease
|
N/A | |
Completed |
NCT02580305 -
SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
|
Phase 2 | |
Recruiting |
NCT02247180 -
Cognitive Rehabilitation in Alzheimer`s Disease
|
N/A | |
Completed |
NCT02317523 -
Alzheimer's Caregiver Coping: Mental and Physical Health
|
N/A | |
Terminated |
NCT02220738 -
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
|
Phase 1 | |
Completed |
NCT02260167 -
Treatment of Alzheimer's and Dementia With the Metabolism, Infections, Nutrition, Drug Elimination (MIND) Protocol
|
N/A | |
Completed |
NCT02256306 -
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study
|
N/A | |
Completed |
NCT01922258 -
Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
|
Phase 3 |